ko	pathway	ratio_in_study	ratio_in_pop	p_value
ko04080	Neuroactive ligand-receptor interaction	76/344	423/7206	1.76780518133e-25
ko05033	Nicotine addiction	25/344	56/7206	5.74823953558e-19
ko04724	Glutamatergic synapse	33/344	152/7206	8.79305633248e-14
ko04727	GABAergic synapse	25/344	110/7206	3.51902093939e-11
ko04728	Dopaminergic synapse	29/344	185/7206	1.05779563911e-08
ko04723	Retrograde endocannabinoid signaling	28/344	175/7206	1.20781565898e-08
ko05032	Morphine addiction	21/344	110/7206	3.76496492395e-08
ko05014	Amyotrophic lateral sclerosis (ALS)	17/344	74/7206	4.45454030449e-08
ko04742	Taste transduction	15/344	61/7206	1.06824101536e-07
ko05030	Cocaine addiction	16/344	73/7206	2.24955474257e-07
ko04713	Circadian entrainment	22/344	136/7206	3.84106329396e-07
ko04721	Synaptic vesicle cycle	16/344	80/7206	8.46908647766e-07
ko04024	cAMP signaling pathway	33/344	279/7206	1.02964293796e-06
ko04726	Serotonergic synapse	21/344	137/7206	1.76530973001e-06
ko04010	MAPK signaling pathway	33/344	321/7206	2.36286552516e-05
ko04725	Cholinergic synapse	20/344	160/7206	6.80229075807e-05
ko04911	Insulin secretion	16/344	117/7206	0.000125762805626
ko04261	Adrenergic signaling in cardiomyocytes	23/344	205/7206	0.000146029739963
ko04921	Oxytocin signaling pathway	23/344	209/7206	0.000176014050555
ko05412	Arrhythmogenic right ventricular cardiomyopathy (ARVC)	12/344	79/7206	0.000328243640313
ko05031	Amphetamine addiction	13/344	91/7206	0.000348052519842
ko04260	Cardiac muscle contraction	13/344	98/7206	0.000721578020505
ko04720	Long-term potentiation	13/344	99/7206	0.000795665319696
ko04730	Long-term depression	11/344	78/7206	0.00109633485338
ko04060	Cytokine-cytokine receptor interaction	1/344	191/7206	0.00158025597877
ko00604	Glycosphingolipid biosynthesis - ganglio series	4/344	14/7206	0.00348858433508
ko04540	Gap junction	14/344	128/7206	0.00483300943524
ko04621	NOD-like receptor signaling pathway	1/344	157/7206	0.00708707168688
ko05322	Systemic lupus erythematosus	1/344	151/7206	0.0104814048993
ko04964	Proximal tubule bicarbonate reclamation	5/344	29/7206	0.011098441441
ko04950	Maturity onset diabetes of the young	5/344	29/7206	0.011098441441
ko04360	Axon guidance	20/344	233/7206	0.0111491952461
ko00910	Nitrogen metabolism	4/344	19/7206	0.0111850682057
ko05168	Herpes simplex infection	2/344	182/7206	0.0125209656713
ko03040	Spliceosome	1/344	145/7206	0.0156615679677
ko05205	Proteoglycans in cancer	5/344	271/7206	0.0188995213795
ko05169	Epstein-Barr virus infection	3/344	206/7206	0.018935798411
ko05414	Dilated cardiomyopathy	11/344	112/7206	0.0215537045137
ko05410	Hypertrophic cardiomyopathy (HCM)	10/344	100/7206	0.0277769691856
ko05145	Toxoplasmosis	1/344	126/7206	0.0316442749442
ko00533	Glycosaminoglycan biosynthesis - keratan sulfate	3/344	15/7206	0.0319984709002
ko01200	Carbon metabolism	1/344	128/7206	0.0324471625318
ko05152	Tuberculosis	3/344	187/7206	0.0357029070459
ko04020	Calcium signaling pathway	20/344	265/7206	0.0387358550491
ko04072	Phospholipase D signaling pathway	16/344	197/7206	0.0391570591519
ko05203	Viral carcinogenesis	6/344	277/7206	0.0422913069824
ko04972	Pancreatic secretion	10/344	111/7206	0.0429196264449
ko04970	Salivary secretion	9/344	95/7206	0.0461842407997
ko02025	Biofilm formation - Pseudomonas aeruginosa	1/344	1/7206	0.0477379961143
ko05016	Huntington's disease	4/344	215/7206	0.0485939784638
ko05166	HTLV-I infection	7/344	292/7206	0.0495390550719
ko04932	Non-alcoholic fatty liver disease (NAFLD)	3/344	182/7206	0.0498092052139